Bioventus Retained Earnings from 2010 to 2024

BVS Stock

USD 11.71 0.20 1.74%

Bioventus Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Bioventus retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2010-12-31

Previous Quarter

-321.5 M

Current Value

-305.5 M

Quarterly Volatility

89.7 M

Credit Downgrade

Yuan Drop

Covid

Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.7 M, Interest Expense of 42.7 M or Total Revenue of 386.8 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 4.0E-4 or PTB Ratio of 1.81. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.

Check out the analysis of Bioventus Correlation against competitors.

For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Latest Bioventus' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Bioventus over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Bioventus' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioventus' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (321.54 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Bioventus Retained Earnings Regression Statistics

	Arithmetic Mean	(125,261,347)
	Coefficient Of Variation	(71.63)
	Mean Deviation	66,121,657
	Median	(139,821,000)
	Standard Deviation	89,728,745
	Sample Variance	8051.2T
	Range	314.9M
	R-Value	(0.72)
	Mean Square Error	4183.7T
	R-Squared	0.52
	Significance	0
	Slope	(14,433,323)
	Total Sum of Squares	112717.5T

Bioventus Retained Earnings History

	2024	-305.5 M
	2023	-321.5 M
	2022	-165.3 M
	2021	-6.6 M
	2020	-144.5 M
	2019	-141.7 M

Other Fundumenentals of Bioventus

Retained Earnings Total Equity

Bioventus Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Tangible Assets	Property Plant Equipment	Long Term Debt	Net Invested Capital	Long Term Investments	Short Long Term Debt	Capital Stock	Net Working Capital	Short Term Investments	Capital Surpluse	Deferred Long Term Liab
Total Assets		0.86	0.17	0.9	-0.22	0.9	0.87	0.11	0.97	0.82	0.65	0.97	-0.66	-0.57	0.71	0.92	0.97	0.43	0.86	-0.89	-0.7	-0.23	-0.23	-0.23
Total Stockholder Equity	0.86		0.44	0.69	0.19	0.58	0.6	0.53	0.72	0.54	0.45	0.79	-0.67	-0.69	0.5	0.7	0.9	0.63	0.52	-0.72	-0.44	-0.08	-0.08	-0.08
Current Deferred Revenue	0.17	0.44		-0.13	0.44	-0.2	0.21	0.85	0.03	0.27	-0.08	-0.03	0.23	0.24	0.24	-0.06	0.22	0.92	-0.06	0.01	0.33	0.36	0.36	0.36
Net Debt	0.9	0.69	-0.13		-0.4	0.94	0.81	-0.11	0.91	0.75	0.72	0.91	-0.77	-0.65	0.66	0.98	0.9	0.16	0.87	-0.93	-0.61	-0.38	-0.38	-0.38
Retained Earnings	-0.22	0.19	0.44	-0.4		-0.46	-0.54	0.73	-0.35	-0.56	-0.42	-0.18	0.14	-0.16	-0.41	-0.47	-0.22	0.28	-0.6	0.52	0.19	0.79	0.79	0.79
Accounts Payable	0.9	0.58	-0.2	0.94	-0.46		0.84	-0.26	0.96	0.78	0.69	0.94	-0.6	-0.5	0.62	0.93	0.83	0.05	0.91	-0.85	-0.8	-0.3	-0.3	-0.3
Net Receivables	0.87	0.6	0.21	0.81	-0.54	0.84		-0.04	0.9	0.99	0.61	0.77	-0.38	-0.16	0.8	0.88	0.86	0.42	0.92	-0.87	-0.51	-0.37	-0.37	-0.37
Good Will	0.11	0.53	0.85	-0.11	0.73	-0.26	-0.04		-0.09	-0.04	-0.17	-0.02	0.06	-0.11	-0.05	-0.12	0.19	0.75	-0.3	0.1	0.34	0.49	0.49	0.49
Total Liab	0.97	0.72	0.03	0.91	-0.35	0.96	0.9	-0.09		0.85	0.67	0.96	-0.59	-0.47	0.72	0.92	0.91	0.28	0.92	-0.87	-0.79	-0.26	-0.26	-0.26
Total Current Assets	0.82	0.54	0.27	0.75	-0.56	0.78	0.99	-0.04	0.85		0.57	0.69	-0.33	-0.07	0.83	0.83	0.81	0.47	0.9	-0.84	-0.43	-0.38	-0.38	-0.38
Short Term Debt	0.65	0.45	-0.08	0.72	-0.42	0.69	0.61	-0.17	0.67	0.57		0.65	-0.61	-0.4	0.65	0.69	0.6	0.15	0.72	-0.67	-0.43	-0.36	-0.36	-0.36
Intangible Assets	0.97	0.79	-0.03	0.91	-0.18	0.94	0.77	-0.02	0.96	0.69	0.65		-0.7	-0.67	0.6	0.9	0.91	0.23	0.83	-0.83	-0.83	-0.18	-0.18	-0.18
Common Stock	-0.66	-0.67	0.23	-0.77	0.14	-0.6	-0.38	0.06	-0.59	-0.33	-0.61	-0.7		0.9	-0.5	-0.75	-0.71	-0.1	-0.59	0.76	0.43	0.46	0.46	0.46
Net Tangible Assets	-0.57	-0.69	0.24	-0.65	-0.16	-0.5	-0.16	-0.11	-0.47	-0.07	-0.4	-0.67	0.9		-0.16	-0.58	-0.61	0.01	-0.32	0.56	0.47	0.2	0.2	0.2
Property Plant Equipment	0.71	0.5	0.24	0.66	-0.41	0.62	0.8	-0.05	0.72	0.83	0.65	0.6	-0.5	-0.16		0.73	0.7	0.48	0.86	-0.74	-0.29	-0.35	-0.35	-0.35
Long Term Debt	0.92	0.7	-0.06	0.98	-0.47	0.93	0.88	-0.12	0.92	0.83	0.69	0.9	-0.75	-0.58	0.73		0.93	0.24	0.92	-0.97	-0.59	-0.47	-0.47	-0.47
Net Invested Capital	0.97	0.9	0.22	0.9	-0.22	0.83	0.86	0.19	0.91	0.81	0.6	0.91	-0.71	-0.61	0.7	0.93		0.48	0.82	-0.94	-0.56	-0.34	-0.34	-0.34
Long Term Investments	0.43	0.63	0.92	0.16	0.28	0.05	0.42	0.75	0.28	0.47	0.15	0.23	-0.1	0.01	0.48	0.24	0.48		0.23	-0.3	0.13	0.14	0.14	0.14
Short Long Term Debt	0.86	0.52	-0.06	0.87	-0.6	0.91	0.92	-0.3	0.92	0.9	0.72	0.83	-0.59	-0.32	0.86	0.92	0.82	0.23		-0.89	-0.64	-0.46	-0.46	-0.46
Capital Stock	-0.89	-0.72	0.01	-0.93	0.52	-0.85	-0.87	0.1	-0.87	-0.84	-0.67	-0.83	0.76	0.56	-0.74	-0.97	-0.94	-0.3	-0.89		0.52	0.61	0.61	0.61
Net Working Capital	-0.7	-0.44	0.33	-0.61	0.19	-0.8	-0.51	0.34	-0.79	-0.43	-0.43	-0.83	0.43	0.47	-0.29	-0.59	-0.56	0.13	-0.64	0.52		0.1	0.1	0.1
Short Term Investments	-0.23	-0.08	0.36	-0.38	0.79	-0.3	-0.37	0.49	-0.26	-0.38	-0.36	-0.18	0.46	0.2	-0.35	-0.47	-0.34	0.14	-0.46	0.61	0.1		1.0	1.0
Capital Surpluse	-0.23	-0.08	0.36	-0.38	0.79	-0.3	-0.37	0.49	-0.26	-0.38	-0.36	-0.18	0.46	0.2	-0.35	-0.47	-0.34	0.14	-0.46	0.61	0.1	1.0		1.0
Deferred Long Term Liab	-0.23	-0.08	0.36	-0.38	0.79	-0.3	-0.37	0.49	-0.26	-0.38	-0.36	-0.18	0.46	0.2	-0.35	-0.47	-0.34	0.14	-0.46	0.61	0.1	1.0	1.0

Click cells to compare fundamentals

About Bioventus Financial Statements

Bioventus shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-321.5 M	-305.5 M
Retained Earnings Total Equity	-5.9 M	-6.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC